Joshua E. Meyer MD

Radiation Oncology•Philadelphia, PA

Gastrointestinal Cancer, Thoracic Cancer

Assistant Professor / Director Residency & Fellowship Programs

Join to View Full Profile

333 Cottman AvenueFox Chase Cancer CenterPhiladelphia, PA 19111
Phone+1 215-728-6900
Fax+1 215-214-1629

Education & Training

New York-Presbyterian Hospital (Cornell Campus)Residency, Radiation Oncology, 2006 - 2010
UMass Chan Medical SchoolInternship, Internal Medicine, 2005 - 2006
University of Massachusetts Medical SchoolClass of 2005

Certifications & Licensure

PA State Medical License 2010 - 2026
NY State Medical License 2012 - 2014
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer Start of enrollment: 1996 Jul 01
Completed
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors Start of enrollment: 2011 Nov 03
Completed
Phase 1
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery Start of enrollment: 2013 May 01
Terminated
Phase 1
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer Start of enrollment: 2014 Feb 01
Completed
Not Applicable
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation Start of enrollment: 2014 Jul 01
Completed
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer Start of enrollment: 2017 Feb 24
Recruiting
Phase 1
Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery Start of enrollment: 2017 Feb 24
Completed
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer Start of enrollment: 2020 Jan 13
ACTIVE_NOT_RECRUITING
NA
Roles: Contact
Local Consolidative Therapy in Colorectal Cancer Start of enrollment: 2021 Jul 29
Withdrawn
Phase 2
Roles: Principal Investigator, Contact
Adaptive Radiation for Abdominopelvic Metastases Start of enrollment: 2023 Aug 01
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Racial/Ethnic Differences and Effects of Clinical/Socioeconomic Factors on Time from Diagnosis to Treatment in Pancreatic Cancer.
Anush Sridharan, Efrat Dotan, Marianna Dorta, Navya Vemula, Elizabeth Handorf
Journal of Gastrointestinal Cancer. 2025-02-15
Palliative Care and End-of-Life Care in Metastatic Pancreatic Cancer.
Jenny O'Brien, Brenton Halsey, Meghan Connors, Mengying Deng, Elizabeth Handorf
Journal of Palliative Medicine. 2025-02-01
Survival outcomes of adjuvant treatment in upstaged clinical T2N0 rectal cancer: are we underutilizing therapy?
Simran Kripalani, Caroline Westwood, Jill S Hasler, Vanessa Wookey, Andrea S Porpiglia
Journal of Gastrointestinal Surgery. 2025-01-01

Authored Content

Local Control and Toxicity of External Beam Reirradiation with Pulsed Low-Dose-Rate TechniqueDecember 2017

Press Mentions

How High Testosterone Levels Have Different Health Outcomes for Men and WomenFebruary 27th, 2020
New Study Supports the Decrease in the Age of the First ColonoscopyJanuary 31st, 2020
CivaTech Oncology Inc. Awarded up to $2.3M from NIH for Pancreatic Cancer Study with CivaSheet® DeviceSeptember 19th, 2016
Join now to see all

Grant Support

Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancerRESEARCH INST OF FOX CHASE CAN CTR2022–2027